While advances in cancer treatment, such as personalized medicine, immunotherapy, and cutting-edge biological therapies, have improved survival rates and quality of life, they often come at a higher price. These advanced treatments are typically more expensive to develop and administer, which can increase the overall cost of care. However, they may also reduce long-term costs by improving outcomes and reducing the need for additional treatments.
